Targeted Therapies for the Evolving Molecular Landscape of Acute Myeloid Leukemia

Targeted Therapies for the Evolving Molecular Landscape of Acute Myeloid Leukemia

Despite considerable growth in our understanding of the heterogeneous biology and pathogenesis of acute myeloid leukemia (AML) in recent decades, for nearly forty years, little progress was gained in the realm of novel therapeutics. Since 2017, however, nine agents have been FDA-approved for patient...

Full description

Bibliographic Details
Main Authors: Khashayar Ahmadmehrabi, Ali R. Haque, Ahmed Aleem, Elizabeth A. Griffiths, Gregory W. Roloff
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
acute myeloid leukemia
therapeutics
targeted therapies
relapse
transplantation
Online Access:https://www.mdpi.com/2072-6694/13/18/4646

Similar Items

Similar Items